Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulations

I tiakina i:

Ngā taipitopito rārangi puna kōrero
I whakaputaina i:	Scientific Reports (Nature Publisher Group) vol. 15, no. 1 (2025), p. 28742-28754
Kaituhi matua:	Khan, Mohd Shahnawaz
Ētahi atu kaituhi:	Shamsi, Anas, Shahwan, Moyad, Dinislam, Khuzin, Yadav, Dharmendra Kumar
I whakaputaina:	Nature Publishing Group
Ngā marau:	Food & Drug Administration > FDA Cancer PD-L1 protein Binders Bioinformatics Therapeutic targets Binding sites Biological products Drug development Computer applications Molecular dynamics Efficiency Proteins Simulation Principal components analysis FDA approval Immune checkpoint Antineoplastic drugs Pharmacokinetics Ligands Immunosuppressive agents Cancer therapies Environmental
Urunga tuihono:	Citation/Abstract Full Text Full Text - PDF
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Me noho koe te mea tuatahi ki te waiho tākupu!